These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 34336739)

  • 21. FBN1: The disease-causing gene for Marfan syndrome and other genetic disorders.
    Sakai LY; Keene DR; Renard M; De Backer J
    Gene; 2016 Oct; 591(1):279-291. PubMed ID: 27437668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An Overview of Investigational and Experimental Drug Treatment Strategies for Marfan Syndrome.
    Deleeuw V; De Clercq A; De Backer J; Sips P
    J Exp Pharmacol; 2021; 13():755-779. PubMed ID: 34408505
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Abnormal extracellular matrix protein transport associated with increased apoptosis of vascular smooth muscle cells in marfan syndrome and bicuspid aortic valve thoracic aortic aneurysm.
    Nataatmadja M; West M; West J; Summers K; Walker P; Nagata M; Watanabe T
    Circulation; 2003 Sep; 108 Suppl 1():II329-34. PubMed ID: 12970255
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Loss of elastic fiber integrity and reduction of vascular smooth muscle contraction resulting from the upregulated activities of matrix metalloproteinase-2 and -9 in the thoracic aortic aneurysm in Marfan syndrome.
    Chung AW; Au Yeung K; Sandor GG; Judge DP; Dietz HC; van Breemen C
    Circ Res; 2007 Aug; 101(5):512-22. PubMed ID: 17641224
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ascending aortic aneurysm with or without features of Marfan syndrome and other fibrillinopathies: new insights.
    Furthmayr H; Francke U
    Semin Thorac Cardiovasc Surg; 1997 Jul; 9(3):191-205. PubMed ID: 9263339
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Autosomal dominant Marfan syndrome caused by a previously reported recessive FBN1 variant.
    Overwater E; Efrat R; Barge-Schaapveld DQCM; Lakeman P; Weiss MM; Maugeri A; van Tintelen JP; Houweling AC
    Mol Genet Genomic Med; 2019 Feb; 7(2):e00518. PubMed ID: 30485715
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The spectrum of FBN1, TGFβR1, TGFβR2 and ACTA2 variants in 594 individuals with suspected Marfan Syndrome, Loeys-Dietz Syndrome or Thoracic Aortic Aneurysms and Dissections (TAAD).
    Lerner-Ellis JP; Aldubayan SH; Hernandez AL; Kelly MA; Stuenkel AJ; Walsh J; Joshi VA
    Mol Genet Metab; 2014 Jun; 112(2):171-6. PubMed ID: 24793577
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Redox stress in Marfan syndrome: Dissecting the role of the NADPH oxidase NOX4 in aortic aneurysm.
    Jiménez-Altayó F; Meirelles T; Crosas-Molist E; Sorolla MA; Del Blanco DG; López-Luque J; Mas-Stachurska A; Siegert AM; Bonorino F; Barberà L; García C; Condom E; Sitges M; Rodríguez-Pascual F; Laurindo F; Schröder K; Ros J; Fabregat I; Egea G
    Free Radic Biol Med; 2018 Apr; 118():44-58. PubMed ID: 29471108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genotype impacts survival in Marfan syndrome.
    Franken R; Groenink M; de Waard V; Feenstra HM; Scholte AJ; van den Berg MP; Pals G; Zwinderman AH; Timmermans J; Mulder BJ
    Eur Heart J; 2016 Nov; 37(43):3285-3290. PubMed ID: 26787436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimising the mutation screening strategy in Marfan syndrome and identifying genotypes with more severe aortic involvement.
    Stengl R; Bors A; Ágg B; Pólos M; Matyas G; Molnár MJ; Fekete B; Csabán D; Andrikovics H; Merkely B; Radovits T; Szabolcs Z; Benke K
    Orphanet J Rare Dis; 2020 Oct; 15(1):290. PubMed ID: 33059708
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Marfan syndrome type II: there is more to Marfan syndrome than fibrillin 1.
    Zangwill SD; Brown MD; Bryke CR; Cava JR; Segura AD
    Congenit Heart Dis; 2006 Sep; 1(5):229-32. PubMed ID: 18377530
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of TGFBR1 and TGFBR2 genetic variants in Marfan syndrome.
    De Cario R; Sticchi E; Lucarini L; Attanasio M; Nistri S; Marcucci R; Pepe G; Giusti B
    J Vasc Surg; 2018 Jul; 68(1):225-233.e5. PubMed ID: 28847661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heart failure and sudden cardiac death in heritable thoracic aortic disease caused by pathogenic variants in the SMAD3 gene.
    Backer J; Braverman AC
    Mol Genet Genomic Med; 2018 May; 6(4):648-52. PubMed ID: 29717556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A cohort study of multiple families with FBN1 p.R650C variant, ectopia lentis, and low but not absent risk for aortopathy.
    Vatti L; Fitzgerald-Butt SM; McBride KL
    Am J Med Genet A; 2017 Nov; 173(11):2995-3002. PubMed ID: 28941062
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bicuspid Aortic Valve: Role of Multiple Gene Variants in Influencing the Clinical Phenotype.
    Sticchi E; De Cario R; Magi A; Giglio S; Provenzano A; Nistri S; Pepe G; Giusti B
    Biomed Res Int; 2018; 2018():8386123. PubMed ID: 30255099
    [No Abstract]   [Full Text] [Related]  

  • 36. A FBN1 3'UTR mutation variant is associated with endoplasmic reticulum stress in aortic aneurysm in Marfan syndrome.
    Siegert AM; García Díaz-Barriga G; Esteve-Codina A; Navas-Madroñal M; Gorbenko Del Blanco D; Alberch J; Heath S; Galán M; Egea G
    Biochim Biophys Acta Mol Basis Dis; 2019 Jan; 1865(1):107-114. PubMed ID: 30385411
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aortopathy in a Mouse Model of Marfan Syndrome Is Not Mediated by Altered Transforming Growth Factor β Signaling.
    Wei H; Hu JH; Angelov SN; Fox K; Yan J; Enstrom R; Smith A; Dichek DA
    J Am Heart Assoc; 2017 Jan; 6(1):. PubMed ID: 28119285
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mild aerobic exercise blocks elastin fiber fragmentation and aortic dilatation in a mouse model of Marfan syndrome associated aortic aneurysm.
    Gibson C; Nielsen C; Alex R; Cooper K; Farney M; Gaufin D; Cui JZ; van Breemen C; Broderick TL; Vallejo-Elias J; Esfandiarei M
    J Appl Physiol (1985); 2017 Jul; 123(1):147-160. PubMed ID: 28385916
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Accelerated Marfan syndrome model recapitulates established signaling pathways.
    Gensicke NM; Cavanaugh NB; Andersen ND; Huang T; Qian L; Dyle MC; Turek JW
    J Thorac Cardiovasc Surg; 2020 May; 159(5):1719-1726. PubMed ID: 31272746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential therapy paradigms for Marfan syndrome.
    Phylactou LA; Kilpatrick MW
    Expert Opin Investig Drugs; 1999 Jul; 8(7):983-93. PubMed ID: 15992100
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.